APA (7th ed.) Citation

I, C. R., S, O., M, P., L, S., J, C., X, T., & N, A. (2025). When Evidence Falls Short-Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal. PharmacoEconomics, 43(8), 845. https://doi.org/10.1007/s40273-025-01505-z

Chicago Style (17th ed.) Citation

I, Corro Ramos, O'Meara S, Patel M, Stirk L, Chen J, Tian X, and Armstrong N. "When Evidence Falls Short-Belzutifan for Treating Tumours Associated with Von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal." PharmacoEconomics 43, no. 8 (2025): 845. https://doi.org/10.1007/s40273-025-01505-z.

MLA (9th ed.) Citation

I, Corro Ramos, et al. "When Evidence Falls Short-Belzutifan for Treating Tumours Associated with Von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal." PharmacoEconomics, vol. 43, no. 8, 2025, p. 845, https://doi.org/10.1007/s40273-025-01505-z.